Metraipolis › archive › dc_391f35e4e0aa

Development of a 12-Valent HPV L1 Virus-like Particle Vaccine Using an Enhanced Baculovirus Expression System — Europe PMC PMID:42188771

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42188771
DOI
10.3390/vaccines14050398
License (as archived)
solo-consultazione
Archived
2026-11-03T02:46:48.871Z
SHA-256 of the archived text
f3c6f9cf2faf7303c584f7e8783140e7bdd353eb05c201ef8701a7d5e880b8ef
Stable URL of this page
https://metraipolis.com/documento/dc_391f35e4e0aa

How to cite

Development of a 12-Valent HPV L1 Virus-like Particle Vaccine Using an Enhanced Baculovirus Expression System — Europe PMC PMID:42188771 — Europe PMC (en), https://europepmc.org/article/MED/42188771 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_391f35e4e0aa (Metraipolis archive dc_391f35e4e0aa, sha256 f3c6f9cf2faf7303c584f7e8783140e7bdd353eb05c201ef8701a7d5e880b8ef)
BibTeX
@misc{dc391f35e4e0aa,
  title = {Development of a 12-Valent HPV L1 Virus-like Particle Vaccine Using an Enhanced Baculovirus Expression System — Europe PMC PMID:42188771},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42188771},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_391f35e4e0aa; sha256 f3c6f9cf2faf7303c584f7e8783140e7bdd353eb05c201ef8701a7d5e880b8ef},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42188771. Agents can read the archived copy with the MCP tool read_document.